Anja von Heydebreck
- Oncology top 0.5%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 1%
- Immunology top 2%
- Cancer Research top 1%
- Co-authors
- Wolfgang HuberMartin VingronAnnemarie PoustkaHolger SültmannKevin M. ChinBastian GunawanJames L. GulleyH. Grote
- Topics
- Cancer Immunotherapy and Biomarkers (28 papers)Polyomavirus and related diseases (14 papers)Gastrointestinal Tumor Research and Treatment (14 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Anja von Heydebreck
93 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 4.0k
- Molecular Biology 2.7k
- Pulmonary and Respiratory Medicine 1.9k
- Immunology 1.4k
- Cancer Research 1.2k
Countries citing papers authored by Anja von Heydebreck
This map shows the geographic impact of Anja von Heydebreck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja von Heydebreck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja von Heydebreck more than expected).
Fields of papers citing papers by Anja von Heydebreck
This network shows the impact of papers produced by Anja von Heydebreck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja von Heydebreck. The network helps show where Anja von Heydebreck may publish in the future.
Co-authorship network of co-authors of Anja von Heydebreck
This figure shows the co-authorship network connecting the top 25 collaborators of Anja von Heydebreck. A scholar is included among the top collaborators of Anja von Heydebreck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja von Heydebreck. Anja von Heydebreck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 9 | |
| 3 | 122 | |
| 4 | 19 | |
| 5 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studybreakdown → | 581 |
| 6 | 1 | |
| 7 | Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial | 1 |
| 8 | 18 | |
| 9 | 2 | |
| 10 | 56 | |
| 11 | EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX studybreakdown → | 453 |
| 12 | 17 | |
| 13 | Relationship of efficacy with kras status (wild type [wt] vs mutant [mt]) in patients with irinotecan-refractory metastatic colorectal cancer (mcrc), treated with irinotecan and escalating doses of cetuximab: preliminary data from the everest study | 1 |
| 14 | 24 | |
| 15 | 34 | |
| 16 | 43 | |
| 17 | 131 | |
| 18 | Variance stabilization applied to microarray data calibration and to the quantification of differential expressionbreakdown → | 1806 |
| 19 | 157 | |
| 20 | 42 |
About Anja von Heydebreck
Anja von Heydebreck is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (28 papers), Polyomavirus and related diseases (14 papers) and Gastrointestinal Tumor Research and Treatment (14 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.2k citations) and Immunology (1.4k citations). Anja von Heydebreck has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Wolfgang Huber, Martin Vingron, Annemarie Poustka, Holger Sültmann, Kevin M. Chin, Bastian Gunawan, James L. Gulley, H. Grote, L. Füzesi and Howard L. Kaufman. Their work appears in journals such as Circulation, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.